본문 바로가기
KERD
논문KCI 등재

표준담배추출물과 Lipopolysaccharide로 유발한 만성폐쇄성폐질환 동물모델에서 쌍화탕의 폐손상 및 근감소 억제 효과

Inhibitory Effects of Ssanghwa-tang on Lung Injury and Muscle Loss in a Cigarette Smoke Extract and Lipopolysaccharide-induced Chronic Obstructive Pulmonary Disease Mouse Model

박양춘|이수원|김승형|우성천|양원경|최진관
대한한방내과학회 (The Society Of Korean Oriental Internal Medicine)|2024.03|대한한방내과학회지 (The Journal of Korean Oriental Internal Medicine)|제45권 제1호|pp. 11-30|DOI 10.22246/jikm.2024.45.1.11

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

Lipopolysaccharide (LPS)muscle losschronic obstructive pulmonary diseaseSsanghwa-tang (SHT)cigarette smoke extract (CSE)
주제분류한의학

초록

Objectives: This study evaluated the effects of Ssanghwa-tang (SHT) on lung injury and muscle loss in a COPD mouse model. Methods: C57BL/6 mice were challenged with cigarette smoke extract and lipopolysaccharide, and then treated with two concentrations of SHT (250 and 500 mg/kg). After sacrifice, the bronchoalveolar lavage fluid (BALF) or lung tissue was analyzed by cytospin, ELISA, real-time PCR, flow cytometry analysis, and H&E and Masson’s trichrome staining. The grip strength of COPD mice was measured using a grip strength meter. The running time of COPD mice was measured by a treadmill test. Muscle tissue of the quadriceps was stained with H&E and Masson’s trichrome staining. Results: SHT significantly inhibited the increase in neutrophil numbers in BALF and significantly decreased immune cell activity in BALF and lung tissue. It also significantly inhibited the increase in TNF-α, IL-17, and MIP2 in BALF. Real-time PCR analysis revealed that the mRNA expression of TNF-α, IL-17, MIP2, and TRPV1 in lung tissue showed a significant decrease compared with the control group. Lung tissue damage was significantly reduced in the histological analysis. The grip strength and running time of the COPD mice showed a significant decrease compared with the control group. In histological staining, SHT was found to reduce the damage to muscle tissue. Conclusions: This study indicates that SHT can be used as a therapeutic agent for COPD patients by inhibiting lung injury and muscle loss.

Abstract

Objectives: This study evaluated the effects of Ssanghwa-tang (SHT) on lung injury and muscle loss in a COPD mouse model. Methods: C57BL/6 mice were challenged with cigarette smoke extract and lipopolysaccharide, and then treated with two concentrations of SHT (250 and 500 mg/kg). After sacrifice, the bronchoalveolar lavage fluid (BALF) or lung tissue was analyzed by cytospin, ELISA, real-time PCR, flow cytometry analysis, and H&E and Masson’s trichrome staining. The grip strength of COPD mice was measured using a grip strength meter. The running time of COPD mice was measured by a treadmill test. Muscle tissue of the quadriceps was stained with H&E and Masson’s trichrome staining. Results: SHT significantly inhibited the increase in neutrophil numbers in BALF and significantly decreased immune cell activity in BALF and lung tissue. It also significantly inhibited the increase in TNF-α, IL-17, and MIP2 in BALF. Real-time PCR analysis revealed that the mRNA expression of TNF-α, IL-17, MIP2, and TRPV1 in lung tissue showed a significant decrease compared with the control group. Lung tissue damage was significantly reduced in the histological analysis. The grip strength and running time of the COPD mice showed a significant decrease compared with the control group. In histological staining, SHT was found to reduce the damage to muscle tissue. Conclusions: This study indicates that SHT can be used as a therapeutic agent for COPD patients by inhibiting lung injury and muscle loss.

참고문헌 (55)

  1. Park YB, "Revised(2018)COPD clinical practice guideline of the Korean Academy of Tuberculosis and Respiratory Disease : a summary", Tuberc Respir Dis, 81(4), pp.261~273 (2018)
  2. O'Donnell DE, "Dyspnea and activity limitation in COPD : mechanical factors", COPD, 4(3), pp.225~236 (2007)
  3. Wagner PD, "Possible mechanisms underlying the development of cachexia in COPD", Eur Respir J, 31(3), pp.492~501 (2008)
  4. Richardson RS, "Evidence of skeletal muscle metabolic reserve during whole body exercise in patients with chronic obstructive pulmonary disease", Am J Respir Crit Care Med, 159(3), pp.881~885 (1999)
  5. Casaburi R, "Skeletal muscle dysfunction in chronic obstructive pulmonary disease", Med Sci Sports Exerc, 33(7 Suppl), pp.S662~S670 (2001)
  6. Lee BJ, "Preliminary Study to Develop a Korean Oriental Medical Assessment Tool for Syndrome Differentiation of Chronic Obstructive Pulmonary Disease", J Korean Oriental Med, 33(3), pp.82~94 (2012)
  7. Lee JG, "Protective effects of Socheongryong-tang on elastase-induced lung injury", J Korean Oriental Med, 32(4), pp.83~99 (2011)
  8. Yang WK, "Effects of GHX02 on Chronic Obstructive Pulmonary Disease Mouse Model", J Korean Oriental Med, 39(4), pp.126~135 (2018)
  9. Park JJ, "Inhibitory effects of SGX01 on lung injury of COPD mice model", Korean J Int Korean Med, 40(4), pp.567~581 (2019)
  10. Kim TH, "Inhibitory effects of GGX on lung injury of chronic obstructive pulmonary Disease mice model", J Korean Med, 42(3), pp.56~71 (2021)
  11. Lee H, "Herbal Formula, PM014, Attenuates Lung Inflammation in a Murine Model of Chronic Obstructive Pulmonary Disease", Evid Based Complement Alternat Med, 2012, pp.769830~ (2012)
  12. Huh J, "Donguibogam", pp.447~ (1998), Namsandang
  13. Nam DJ, "Review about the study of Ssanghwa-tang published in Korea from 2000to 2019", J Haehwa Med, 28(2), pp.12~19 (2019)
  14. Park WK, "Effects of Ssanghwa-tang on the Antifatigue Action and Brain Levels of Norepinephrine, Serotonin, 5-hydroxyindole-acetic acid and Dopamine", J Jeahan Oriental Med Academy, 1(1), pp.130~145 (1995)
  15. Jung D, "Stimulation of the immune response by Yin-tonifying formula", J Korean Oriental Med, 31(5), pp.112~123 (2010)
  16. Jung HJ, "Effects of one bout administration of oriental herbal drink on aerobic capacity and physiological valuables in elite long-distance runners", J Oriental Rehab Med, 17(3), pp.161~177 (2007)
  17. Choi JY, "Randomized, double-blind, and placebo-controlled a clinical study for chronic fatigue via the analysis of efficacy and safety of Gongjin-dan and Ssanghwa-tang : study protocol", J Soc of Prev Korean Med, 26(3), pp.97~108 (2022)
  18. Tanaka H, "The effect of allergen-induced airway inflammation on airway remodeling in a murine model of allergic asthma", Inflamm Res, 50(12), pp.616~624 (2001)
  19. Hah YS, "Anti-atrophic effect of green tea extracts from different extraction processes on dexamethasone-induced atrophy in cellular and mouse model", J Kor Tea Soc, 26(1), pp.40~50 (2020)
  20. Dougherty JP, "The treadmill fatigue test : a simple, highthroughput assay of fatigue-like behavior for the mouse", J Vis Exp, (111), pp.e54052~ (2016)
  21. Lopez AD, "Chronic obstructive pulmonary disease : current burden and future projections", Eur Rspir J, 27(2), pp.397~412 (2006)
  22. Adeloye D, "NIHR RESPIRE Global Respiratory Health Unit. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease(COPD)in 2019 : a systematic review and modelling analysis", Lancet Respir Med, 10(5), pp.447~458 (2022)
  23. Kim SH, "Recent Prevalence of and Factors Associated With Chronic Obstructive Pulmonary Disease in a Rapidly Aging Society:Korea National Health and Nutrition Examination Survey 2015-2019", J Korean Med Sci, 38(14), pp.e108~ (2015)
  24. Hogg JC, "Pathophysiology of airflow limitation in chronic obstructive pulmonary disease", Lancet, 364(9435), pp.709~721 (2004)
  25. Barnes PJ, "Cellular and molecular mechanisms of asthma and COPD", Clin Sci(Lond), 131(13), pp.1541~1558 (2017)
  26. Abboud RT, "Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema", Int J Tuberc Lung Dis, 12(4), pp.361~367 (2008)
  27. Cruz-Jentoft AJ, "Sarcopenia : revised European consensus on definition and diagnosis", Age Ageing, 48(4), pp.601~ (2019)
  28. Sepulveda-Loyola W, "Diagnosis, prevalence, and clinical impact of sarcopenia in COPD : a systematic review and meta-analysis", J Cachexia Sarcopenia Muscle, 11(5), pp.1164~1176 (2020)
  29. Jones SE, "Sarcopenia in COPD : prevalence, clinical correlates and response to pulmonary rehabilitation", Thorax, 70(3), pp.213~218 (2015)
  30. Jaitovich A, "Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease. What We Know and Can Do for Our Patients", Am J Respir Crit Care Med, 198(2), pp.175~186 (2018)
  31. Tanimura K, "Quantitative Assessment of Erector Spinae Muscles in Patients With Chronic Obstructive Pulmonary Disease. Novel Chest Computed Tomography-Derived Index for Prognosis", Ann Am Thorac Soc, 13(3), pp.334~341 (2016)
  32. Yum JY, "Effects of Samultang on immune function during the late stage of pregnancy in Balb", c mice, 2000, pp.31(2), 142~148
  33. Lee SY, "Effect of Astragalus membranaceus Polysaccharides on improves immune response after exhaustive exercise rats", Korean J Medicinal Crop Sci, 26(1), pp.72~81 (2018)
  34. Kamei J, "Antitussive principles of Glycyrrhizae radix, a main component of the Kampo preparations Bakumondo-to(Mai-men-dong-tang)", Eur J Pharmacol, 469(1-3), pp.159~163 (2003)
  35. Kim SH, "18β-Glycyrrhetinic acid, the major bioactive component of Glycyrrhizae Radix, attenuates airway inflammation by modulating Th2 cytokines, GATA-3, STAT6, and Foxp3 transcription factors in an asthmatic mouse model", Environ Toxicol Pharmacol, 52, pp.99~113 (2017)
  36. Ko HM, "Gancaonin N from Glycyrrhiza uralensis Attenuates the Inflammatory Response by Downregulating the NF-κB", MAPK Pathway on an Acute Pneumonia In Vitro Model, 2021, pp.13(7), 1028~
  37. Khan AM, "Zingiber officinale ameliorates allergic asthma via suppression of Th2-mediated immune response", Pharm Biol, 53(3), pp.359~367 (2015)
  38. Kim SA, "The study on chemical components and oriental medicinal effects onf Jujuba Fructus", J East-West Med, 37(3), pp.1~11 (2012)
  39. Percopo CM, "SiglecF+Gr1hi eosinophils are a distinct subpopulation within the lungs of allergen-challenged mice", J Leukoc Biol, 101(1), pp.321~328 (2017)
  40. Angata T, "Cloning and characterization of a novel mouse Siglec, mSiglec-F : differential evolution of the mouse and human(CD33)Siglec-3-related gene clusters", J Biol Chem, 276(48), pp.45128~45136 (2001)
  41. Spoelstra FM, "Changes in CD11b and L-selectin expression on eosinophils are mediated by human lung fibroblasts in vitro", Am J Respir Crit Care Med, 158(3), pp.769~777 (1998)
  42. Lokwani R, "Blood Neutrophils In COPD But Not Asthma Exhibit A Primed Phenotype With Downregulated CD62L Expression", Int J Chron Obstruct Pulmon Dis, 14, pp.2517~2525 (2019)
  43. DeGrendele HC, "Requirement for CD44 in activated T cell extravasation into an inflammatory site", Science, 24(278), pp.672~675 (1997)
  44. Deveci Y, "Serum ghrelin, IL-6 and TNF-αlevels in patients with chronic obstructive pulmonary disease", Tuberk Toraks, 58(2), pp.162~172 (2010)
  45. Barnes PJ, "Inflammatory mechanisms in patients with chronic obstructive pulmonary disease", J Allergy Clin Immunol, 138(1), pp.16~27 (2016)
  46. Freeman CM, "Cytotoxic potential of lung CD8+ T cells increases with chronic obstructive pulmonary disease severity and with in vitro stimulation by IL-18 or IL-15", J Immunol, 184(11), pp.6504~6513 (2010)
  47. Aaron SD, "Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease", Am J Respir Crit Care Med, 163(2), pp.349~355 (2001)
  48. Traves SL, "Th17 cells in airway diseases", Curr Mol Med, 8(5), pp.416~426 (2008)
  49. Levanen B, "Impact of tobacco smoking on cytokine signaling via interleukin-17A in the peripheral airways", Int J Chron Obstruct Pulmon Dis, 11, pp.2109~2116 (2016)
  50. Henrot P, "Chemokines in COPD : From Implication to Therapeutic Use", Int J Mol Sci, 20(11), pp.2785~ (2019)
  51. Chung KF, "Prevalence, pathogenesis, and causes of chronic cough", Lancet, 371(9621), pp.1364~1374 (2008)
  52. Baraldo S, "Pathophysiology of the small airways in chronic obstructive pulmonary disease", Respiration, 84(2), pp.89~97 (2012)
  53. Maltais F, "An official American Thoracic Society", European Respiratory Society statement : update on limb muscle dysfunction in chronic obstructive pulmonary disease, 2014, pp.189(9), e15~e62
  54. Ma K, "Pathogenesis of sarcopenia in chronic obstructive pulmonary disease", Front Physiol, 13, pp.850964~ (2022)
  55. Byun MK, "Sarcopenia correlates with systemic inflammation in COPD", Int J Chron Obstruct Pulmon Dis, 12, pp.669~675 (2017)

관련 논문AI추천

만성폐쇄성폐질환 및 미세먼지 유발 폐손상 동물모델에서 과루행련환의 효과김승형, 박양춘, 양원경, 유이란, 이철화대한한방내과학회 · 대한한방내과학회지2017 · 제38권 제3호만성폐쇄성폐질환 동물모델에서 SGX01의 폐손상 억제 효과김승형, 박양춘, 박재준, 양원경, 유이란대한한방내과학회 · 대한한방내과학회지2019 · 제40권 제4호LPS로 유발된 만성폐쇄성폐질환에 대한 生脈淸肺飮의 영향김용, 김민희, 남궁욱, 박양춘, 양수영대한한방내과학회 · 대한한방내과학회지2011 · 제32권 제2호Inhibitory Effects of Angelicae Dahuricae Radix Extract on COPD induced by Cigarette Smoke Condensate and Lipopolysaccharide in Mice곽호근, 임흥빈한국약용작물학회 · 한국약용작물학회지2011 · 제19권 제5호柴梗半夏湯이 LPS로 유발된 급성 폐손상에 대한 영향고흥, 김기태한의병리학회 · 동의생리병리학회지2009 · 제23권 제6호미세먼지 in vivo 모델에서 호흡기 질환에 대한 한약의 효과에 관한 연구 동향 분석박양춘, 우성천, 이수원대한한방내과학회 · 대한한방내과학회지2023 · 제44권 제3호

이 간행물의 다른 논문 (8건)

파킨슨병 변증 유형 및 지표 분포에 대한 전향적 다기관 관찰연구 프로토콜박성욱, 권오진, 유호룡, 서복남, 장정희, 조혜연pp. 1-10수술 후 발생한 유방암 연관 림프 부종(BCRL)에 대한 황기계지오물탕(黃芪桂枝五物湯)의 효과 : 체계적 문헌 고찰 및 메타 분석김예슬, 김경민, 김영균, 이영서pp. 31-54VigiAccess를 통한 WHO의 약물 이상사례 보고 현황 검색과 그 활용 가능성 탐색 : 비만 치료제를 중심으로김미경pp. 55-74척수경색 환자의 보행불가 증상에 대한 한의복합치료 1례박현서, 김선중, 하지수, 김진원pp. 75-86Temporomandibular Joint Balancing Therapy(턱관절 균형요법)를 병행한 한의치료로 호전된 특발성 파킨슨병 환자 2례에 대한 증례보고유호룡, 김승호, 허준영, 이영준, 설인찬, 신주은, 김윤식pp. 87-99
원문 보기